Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M van Weerden

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Human Gene Therapy|August 31, 2011
A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancerM K Magnusson, R Kraaij, R M Leadley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2011
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenograftsRogier P J Schroeder, W M van Weerden, E P Krenning, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Human Gene Therapy|August 31, 2011
A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancerM K Magnusson, R Kraaij, R M Leadley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2011
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenograftsRogier P J Schroeder, W M van Weerden, E P Krenning, et al.
Pageof 4